Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

被引：0
|
作者：
Landau, AO
Batisse, DP
van Huen, PD
Piketty, C
Bloch, F
Pialoux, G
Petite, JP
Weiss, L
Kazatchkine, M
机构：
[1] Hosp Broussais, Paris, France
[2] Hosp Rothschild, Paris, France
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
828
引用
收藏
页码：367A / 367A
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Van Huyen, JPD
    Piketty, C
    Bloch, F
    Pialoux, G
    Belec, L
    Petite, JP
    Weiss, L
    Kazatchkine, M
    [J]. AIDS, 2000, 14 (07) : 839 - 844
  • [2] Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Piketty, C
    Van Huyen, LPD
    Bloch, F
    Belec, L
    Bruneval, P
    Weiss, L
    Jian, R
    Kazatchkine, MD
    [J]. AIDS, 2001, 15 (16) : 2149 - 2155
  • [3] Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis C
    Perez-Olmeda, M
    Asensi, V
    Romero, M
    Sanchez-Montero, F
    Santin, M
    Ochoa, A
    Guardiola, J
    Blanch, J
    Garcia-Samaniego, J
    Soriano, V
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 108 - 108
  • [4] Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
    Pérez-Olmeda, M
    Romero, M
    Asensi, V
    Sanchez-Montero, R
    Ochoa, A
    García-Samaniego, J
    Soriano, V
    [J]. HEPATOLOGY, 2001, 34 (04) : 332A - 332A
  • [5] Efficacy and safety of pegylated interferon-α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Santin, M
    Shaw, E
    Garcia, MJ
    Delejido, A
    De Castro, ER
    Rota, R
    Altés, J
    Baguena, F
    Valero, S
    Sala, M
    Casanova, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) : 315 - 320
  • [6] Treatment of chronic hepatitis C in HIV-infected patients with interferon α-2b plus ribavirin
    Pérez-Olmeda, M
    Soriano, V
    Asensi, V
    Morales, D
    Romero, M
    Ochoa, A
    Sánchez-Montero, F
    Santin, M
    Guardiola, J
    Blanch, J
    Núñez, M
    Jiménez-Nácher, I
    García-Samaniego, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (12) : 1083 - 1089
  • [7] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    [J]. AIDS, 2004, 18 (01) : 67 - 73
  • [8] Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
    Callens, S
    Bottieau, E
    Michielsen, P
    Colebunders, R
    [J]. AIDS, 2004, 18 (01) : 131 - 131
  • [9] EFFICACY AND SAFETY OF PEGYLATED INTERFERON-ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS
    Dai, C. -Y.
    Huang, C. -F.
    Yu, M. -L
    Huang, J-F
    Chuang, W-L.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S227 - S227
  • [10] Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection
    Tsubota, A
    Hirose, Y
    Izumi, N
    Kumada, H
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 360 - 367
12345